Texas 2017 - 85th Regular

Texas House Bill HB2626

Voted on by House
 
Out of Senate Committee
 
Voted on by Senate
 
Governor Action
 
Bill Becomes Law
 

Caption

Relating to administrative and other expenditures by Medicaid managed care organizations.

Impact

The bill is expected to have a significant impact on state Medicaid laws by instituting stricter controls on how managed care organizations allocate their budgets. Through mandatory annual reports, these organizations will need to disclose their spending on administrative functions compared to actual healthcare delivery services. This could lead to more accountability and potentially better health outcomes for enrollees, as more funds may be prioritized for direct healthcare provision rather than overhead and marketing.

Summary

House Bill 2626 addresses regulatory provisions related to the management of Medicaid funds, specifically focusing on limiting the administrative and overhead expenditures that Medicaid managed care organizations can incur. The bill empowers the legislature, in consultation with the commission, to set upper limits on the percentage or amount that can be spent on administrative costs, thereby directing more funds toward clinical services for enrollees. This change aims to increase the efficiency of Medicaid services and ensure that resources are more effectively allocated towards healthcare quality and provision.

Contention

Despite its goals, the bill has faced concerns regarding the potential implications of such expenditure caps. Critics may argue that limiting administrative costs could inadvertently reduce the ability of managed care organizations to effectively operate and market their services, potentially leading to a decrease in competition or quality of care. Additionally, there may be apprehensions about how these regulations will interact with federal requirements or existing frameworks, especially if federal waivers are needed for compliance.

Notable_points

In the broader context, HB2626 aligns with ongoing discussions in health policy regarding the management of Medicaid funds and the pursuit of both cost containment and quality enhancement. Notably, there may be differing opinions on the balance between regulatory oversight and the operational flexibility that managed care organizations require to adapt to changing healthcare landscapes.

Companion Bills

No companion bills found.

Previously Filed As

TX HB113

Relating to the use of community health workers in Medicaid managed care.

TX SB74

Relating to the use of community health workers in Medicaid managed care.

TX HB5023

Relating to requiring Medicaid managed care organizations to provide an annual bonus payment to certain Medicaid providers.

TX SB2244

Relating to certain evidence-based community support services offered by a Medicaid managed care organization in lieu of other services.

TX SB2402

Relating to the creation, management, and administration of the Texas Pharmaceutical Initiative.

TX HB4611

Relating to the nonsubstantive revision of the health and human services laws governing the Health and Human Services Commission, Medicaid, and other social services.

TX HB5018

Relating to certain payment recovery efforts by managed care organizations under Medicaid or the child health plan program.

TX HB1701

Relating to administrative and judicial review of certain Medicaid reimbursement disputes; authorizing a fee.

TX HB1283

Relating to prescription drug formularies applicable to the Medicaid managed care program.

TX SB1113

Relating to prescription drug formularies applicable to the Medicaid managed care program.

Similar Bills

No similar bills found.